Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ALNA

Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, ALLN-177, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS Invesco Russell 2000 Equal Weight ETF 21.1 M 2.11E+07 1,977 1977 0.03% 0.00025 5 K 5269
IWC iShares Microcap ETF 882.1 M 8.82078E+08 1,449 1449 0.03% 0.0003 254 K 254193
IWM iShares Russell 2000 ETF 45.0 B 4.50056E+10 2,022 2022 0.0% 0 2.2 M 2222730
IWO iShares Russell 2000 Growth ETF 9.3 B 9.31244E+09 1,240 1240 0.01% 0.0001 930 K 929691
IWV iShares Russell 3000 ETF 8.4 B 8.44137E+09 3,007 3007 0.0% 0 50 K 50215
SBIO ALPS Medical Breakthroughs ETF 229.3 M 2.29267E+08 112 112 0.13% 0.0013 298 K 298047
URTY ProShares UltraPro Russell2000 115.9 M 1.15878E+08 2,033 2033 0.0% 8.62174E-06 3 K 3401
UWM ProShares Ultra Russell2000 169.7 M 1.697E+08 2,033 2033 0.0% 1.94621E-05 7 K 7060
WMCR Invesco Wilshire Micro-Cap ETF 26.3 M 2.63E+07 1,083 1083 0.07% 0.00073 19 K 19123

Wait, Before You Leave...